A federal appeals court had signed off on a deal that would shield members of the wealthy Sackler family from lawsuits in exchange for billions for those harmed by the opioid epidemic.
Category: Opioids and Opiates
-
Supreme Court Pauses Purdue Pharma Bankruptcy Deal
A federal appeals court had signed off on an agreement, now on hold, that would shield members of the wealthy Sackler family from opioid-related lawsuits in exchange for $6 billion for victims.
-
‘American Pain’ Review: When the Pills and the Money Kept On Flowing
Darren Foster’s documentary offers an energetic profile of twin brothers who operated a slick drug trafficking operation in South Florida.
-
An Appeals Court Gave the Sacklers Legal Immunity. Here’s What the Ruling Means.
In return for the shield, the billionaire owners of Purdue Pharma are committed to paying up to $6 billion to help compensate communities and individuals for the ravages of the opioid epidemic.
-
Sacklers Can Be Shielded From Opioid Liability, Appeals Court Rules
The decision gives the Purdue Pharma owners long-sought protection, but it will release billions of dollars from their fortune to states and communities to help cope with the costs of addiction.
-
Addiction Treatment Medicine Is Vastly Underprescribed, Especially by Race, Study Finds
Black patients with opioid use disorder were far less likely to fill prescriptions for the most effective addiction treatments than white patients. But strikingly few patients of all races got the medicine.
-
National Academies Members Demand Answers About Sacklers’ Donations
The Academies accepted millions of dollars from members of the Sackler family — including some who led Purdue Pharma, makers of OxyContin — even while advising federal officials on opioid policy.
-
Sacklers Gave Millions to Institution That Advises on Opioid Policy
Even as the nation’s drug crisis mounted, the National Academies of Sciences, Engineering and Medicine continued to accept funds from some members of the Sackler family, including those involved with Purdue Pharma.
-
The Fight Over a Drug That Is Great for Horses but Horrific for Humans
Drug dealers are mixing xylazine, an animal tranquilizer relied on by veterinarians, into fentanyl, with deadly results. But controlling it is tricky.
-
F.D.A. Approves Narcan for Over-the-Counter Sales
The New York Times – Business:The nasal spray reverses opioid overdoses and public health officials hope that making it more widely available could save lives and reduce the nation’s high rates of drug fatalities.
-
Over-the-Counter Narcan Could Save More Lives. But Price and Stigma Are Obstacles
The New York Times – Business:The Food and Drug Administration is expected this week to allow the overdose-reversal medication to be sold without a prescription, a step toward making it a common emergency tool.
-
How an Opioid Settlement Hinders Patients’ Access to ADHD Medication and Other Drugs
The New York Times – Business:An agreement between attorneys general and major drug distributors increased scrutiny on medications for A.D.H.D., addiction, anxiety and pain.